Ionis Pharmaceuticals Inc Update on Clinical Studies Evaluating Tominersen (IONIS-HTT Rx) Summary - Thomson StreetEvents

Ionis Pharmaceuticals Inc Update on Clinical Studies Evaluating Tominersen (IONIS-HTT Rx) Summary

Ionis Pharmaceuticals Inc Update on Clinical Studies Evaluating Tominersen (IONIS-HTT Rx) Summary - Thomson StreetEvents
Ionis Pharmaceuticals Inc Update on Clinical Studies Evaluating Tominersen (IONIS-HTT Rx) Summary
Published Mar 22, 2021
18 pages (8998 words) — Published Mar 22, 2021
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Brief of IONS.OQ conference call or presentation 22-Mar-21 9:00pm GMT

  
Brief Excerpt:

...A. Overview: As Co. and partner Roche announced on 03/22/21, Roche decided to discontinue dosing in Phase III GENERATION HD1 study of tominersen in patients with Huntington's disease. 1. 2. Roche's decision was based on results of pre-planned review of data from ongoing Phase III study, which was conducted by unblinded Independent Data Monitoring Committee (iDMC). While no new or emerging safety signals identified, iDMC made recommendation based on tominersen's potential benefit/risk profile. a. 3. Roche will continue to follow participants from Phase III study to assess additional safety and clinical data....

  
Report Type:

Brief

Source:
Company:
Ionis Pharmaceuticals Inc
Ticker
IONS.OQ
Time
9:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Ionis Pharmaceuticals Inc at Needham Healthcare Conference (Virtual) Transcript – 2021-04-12 – US$ 54.00 – Edited Transcript of IONS.OQ presentation 12-Apr-21 2:15pm GMT

Ionis Pharmaceuticals Inc Rare Disease Webinar Series: Hereditary Angioedema Transcript – 2021-04-05 – US$ 54.00 – Edited Transcript of IONS.OQ conference call or presentation 5-Apr-21 4:00pm GMT

Ionis Pharmaceuticals Inc at Stifel CNS Day Transcript – 2021-04-01 – US$ 54.00 – Edited Transcript of IONS.OQ presentation 1-Apr-21 4:00pm GMT

Ionis Pharmaceuticals Inc at JPMorgan NAPA Valley Forum (Virtual) Transcript – 2021-03-29 – US$ 54.00 – Edited Transcript of IONS.OQ presentation 29-Mar-21 8:00pm GMT

Ionis Pharmaceuticals Inc Update on Clinical Studies Evaluating Tominersen (IONIS-HTT Rx) Transcript – 2021-03-22 – US$ 54.00 – Edited Transcript of IONS.OQ conference call or presentation 22-Mar-21 9:00pm GMT

Ionis Pharmaceuticals Inc at Oppenheimer Healthcare Conference (Virtual) Transcript – 2021-03-17 – US$ 54.00 – Edited Transcript of IONS.OQ presentation 17-Mar-21 2:40pm GMT

Ionis Pharmaceuticals Inc at SVB Leerink Global Healthcare Conference (Virtual) Transcript – 2021-02-26 – US$ 54.00 – Edited Transcript of IONS.OQ presentation 26-Feb-21 4:20pm GMT

Ionis Pharmaceuticals Inc Q4 2020 Earnings Call Summary – 2021-02-24 – US$ 54.00 – Edited Brief of IONS.OQ earnings conference call or presentation 24-Feb-21 2:00pm GMT

Ionis Pharmaceuticals Inc Q4 2020 Earnings Call Transcript – 2021-02-24 – US$ 54.00 – Edited Transcript of IONS.OQ earnings conference call or presentation 24-Feb-21 2:00pm GMT

Ionis Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript – 2021-01-12 – US$ 54.00 – Edited Transcript of IONS.OQ presentation 12-Jan-21 8:40pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Ionis Pharmaceuticals Inc Update on Clinical Studies Evaluating Tominersen (IONIS-HTT Rx) Summary" Mar 22, 2021. Alacra Store. May 19, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Ionis-Pharmaceuticals-Inc-Update-on-Clinical-Studies-Evaluating-Tominersen-IONIS-HTT-Rx-B14633264>
  
APA:
Thomson StreetEvents. (2021). Ionis Pharmaceuticals Inc Update on Clinical Studies Evaluating Tominersen (IONIS-HTT Rx) Summary Mar 22, 2021. New York, NY: Alacra Store. Retrieved May 19, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Ionis-Pharmaceuticals-Inc-Update-on-Clinical-Studies-Evaluating-Tominersen-IONIS-HTT-Rx-B14633264>
  
US$ 54.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.